Skip to main content

and
  1. No Access

    Article

    The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models

    Multiple myeloma (MM) is a B-cell malignancy, which often remains incurable because of the development of drug resistance governed by the bone marrow (BM) microenvironment. Novel treatment strategies are there...

    S Deleu, M Lemaire, J Arts, E Menu, E Van Valckenborgh, P King, I Vande Broek in Leukemia (2009)

  2. No Access

    Article

    Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells

    J Caers, S Deleu, Z Belaid, H De Raeve, E Van Valckenborgh, E De Bruyne in Leukemia (2007)